Filing Details

Accession Number:
0001209191-14-030396
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-01 19:48:41
Reporting Period:
2014-04-29
Filing Date:
2014-05-01
Accepted Time:
2014-05-01 19:48:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNTU In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1056630 Zubeen Shroff Elizabeth House, 9 Castle Street
St Helier Y9 JE2 3RT
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-04-30 287,914 $0.00 5,093,820 No 4 P Indirect By Galen Partners V LP
Ordinary Shares Acquisiton 2014-04-30 24,586 $0.00 434,978 No 4 P Indirect By Galen Partners International V LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Galen Partners V LP
No 4 P Indirect By Galen Partners International V LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Acquisiton 2014-04-29 5,000 $0.00 5,000 $8.00
Ordinary Shares Ordinary Share Warrants Acquisiton 2014-04-30 287,914 $8.00 230,331 $0.00
Ordinary Shares Ordinary Share Warrants Acquisiton 2014-04-30 24,586 $8.00 19,669 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2024-04-29 No 4 A Direct
287,914 2014-07-24 2015-10-25 No 4 P Indirect
24,586 2014-07-24 2015-10-25 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 150,704 Indirect Galen Management, LLC
Footnotes
  1. In connection with Quotient Limited's initial public offering, 287,914 units were purchased by Galen Partners V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one Ordinary Share and one warrant to purchase 0.8 of one Ordinary Share. The units currently trade on NASDAQ. The Ordinary Shares and warrants comprising the units will begin trading separately on May 24, 2014, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on July 24, 2014 and ending at 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
  2. Consists solely of 5,093,820 ordinary shares held of record by Galen Partners V LP, 434,978 ordinary shares held of record by Galen Partners International V LP and 150,704 ordinary shares held of record by Galen Management, LLC (collectively, "Galen Partners"), as applicable. Zubeen Shroff along with David W. Jahns, and John Wilkerson exercise voting, investment and dispositive rights over the securities held of record by Galen Partners. Mr. Shroff disclaims beneficial ownership of these ordinary shares, except to the extent of his proportionate pecuniary interest in such shares.
  3. In connection with Quotient Limited's initial public offering, 24,586 units were purchased by Galen Partners International V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one Ordinary Share and one warrant to purchase 0.8 of one Ordinary Share. The units currently trade on NASDAQ. The Ordinary Shares and warrants comprising the units will begin trading separately on May 24, 2014, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on July 24, 2014 and ending at 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
  4. The option becomes exercisable in three equal annual installments beginning April 29, 2015.